Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

KILITCH DRUGS (INDIA) LTD. - 524500 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, we hereby intimate you that the Company has received letter in relation with loss of Share Certificate from the Registrar and Share Transfer Agents of the Company i.e. Link Intime India Private Limited. Further the request for issue of duplicate share certificate has also been received with respect to the same.
12-05-2023
Bigul

KILITCH DRUGS (INDIA) LTD. - 524500 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyKILITCH DRUGS (INDIA) LTD. 2CIN NO.L24239MH1992PLC066718 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 1.46 4Highest Credit Rating during the previous FY na 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Pushpa Nyoupane Designation: Company Secretary and Compliance Officer EmailId: pushpanyoupane@kilitch.com Name of the Chief Financial Officer: Sunil Jain Designation: Chief Financial Officer EmailId: suniljain@kilitch.com Date: 25/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
25-04-2023
Bigul

KILITCH DRUGS (INDIA) LTD. - 524500 - Certificate Under Regulation 40(9) Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015

 With reference to Regulation 40(9) of Securities Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed herewith the certificate dated 17th April, 2023 received from M/s. Deep Shukla & Associates, Practicing Company Secretaries for the year ended 31st March 2023.
17-04-2023
Bigul

KILITCH DRUGS (INDIA) LTD. - 524500 - Compliance Certificate Pursuant To Regulation 7(3) Of SEBI (Listing Obligations And Disclosures Requirements) Regulations, 2015 For The Year Ended 31St March, 2023

 Please find enclosed Compliance Certificate pursuant to the Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the year ended March 31, 2023.
15-04-2023
Bigul

KILITCH DRUGS (INDIA) LTD. - 524500 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulation, 2018, enclosed herewith is the Certificate received from Link Intime India Private Limited, the Registrar and Share Transfer Agent of the Company for the quarter ended 31st March, 2023.
12-04-2023
Bigul

KILITCH DRUGS (INDIA) LTD. - 524500 - Voting Results And Scrutinizer'S Report On Voting Of The Extraordinary General Meeting Held On 11Th April, 2023

 As per the requirements of the Companies Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, the Company had provided remote e-voting and e-voting facility (during EGM) to its members on the business transacted at the Extraordinary General Meeting (EGM) of the Company held on Tuesday, 11th April, 2023 at 9:00 A.M. through Video Conferencing (VC)/Other Audio Video Means (OAVM). The Company had appointed M/s. Deep Shukla & Associates, Practicing Company Secretary as the scrutinizer for conducting the e-voting process. The Scrutinizers' Report and Voting Results is enclosed herewith.
12-04-2023
Bigul

KILITCH DRUGS (INDIA) LTD. - 524500 - Proceedings Of Extraordinary General Meeting Of The Company Held On Tuesday, 11Th April, 2023

 This is to inform you that the Extraordinary General Meeting of the members of Kilitch Drugs (India) Limited was held today i.e. Tuesday, the 11th day of April, 2023 at 9:00 am through Video Conferencing (VC)/ Other Audio Visual Means (OAVM). In this regard, please find enclosed the proceedings as required under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
11-04-2023
Bigul

KILITCH DRUGS (INDIA) LTD. - 524500 - Closure of Trading Window

 Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time read with Code of Prohibition of Insider Trading of the Company, the Trading Windows for dealing in Securities of the Company will remain closed for all the Designated Persons of the Company and their immediate relatives with effect from Saturday, 1st April, 2023 till the expiry of 48 hours after the declaration of Financial Results of the Company for the quarter and year ended 31st March, 2023
29-03-2023
Bigul

KILITCH DRUGS (INDIA) LTD. - 524500 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 30 and 47 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015 ('Listing Regulations'), please find enclosed herewith the copy of Newspaper Publication published on Sunday, 19th March, 2023 in the Free Press Journal - English Edition and Nava Shakti - Marathi Edition pertaining to Notice of Extraordinary General Meeting and e-voting details.
20-03-2023
Bigul

KILITCH DRUGS (INDIA) LTD. - 524500 - Notice Of Extraordinary General Meeting To Be Held On Tuesday, 11Th April, 2023

 We would like to inform you that Extraordinary General Meeting (EGM) of the Company will be held on Tuesday, 11th April, 2023, at 9:00 am (IST) through Video Conferencing or Other Audio Visual Means.
18-03-2023
Next Page
Close

Let's Open Free Demat Account